John is an entrepreneur with dual expertise in cancer biology and financial economics. He has over 10 years’ experience in drug development; spanning academia (University of Cambridge), industry (MedImmune) and startups. John is founder, and currently serves as Executive Chairman, of CCG.ai, a Y Combinator backed startup bringing AI to precision oncology.
John holds a Masters in Pharmacology (1st Class; top UK graduate of 2014) from the University of Glasgow, a PhD in Functional Genomics from the University of Cambridge, and an MBA focused on health economics.
In 2018 John was honoured on the Forbes 30 Under 30 (Europe) list for his contributions to biotechnology and in 2020 he became the youngest Fellow of the Royal Society of Biology (FRSB). Aside from his work at Selvedge, John is currently a Venture Partner at Kindred Capital and Entrepreneur in Residence at Oxford Science Innovation.